New drug tested to tame devastating autoimmune attacks
NCT ID NCT01532570
Summary
This study tested a drug called TA-650 in 18 people with severe, hard-to-treat Behcet's disease. The goal was to see if regular infusions could make the disease's serious symptoms disappear and reduce inflammation. Researchers measured improvements in ulcers, brain lesions, and blood vessel damage over about a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHCET'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Chūbu, Japan
-
Investigational site
Hokkaido, Japan
-
Investigational site
Kanto, Japan
-
Investigational site
Kinki, Japan
-
Investigational site
Kyusyu, Japan
-
Investigational site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.